Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1961 8
1962 2
1963 2
1964 1
1965 2
1968 2
1971 2
1973 1
1974 2
1975 3
1976 4
1977 3
1978 4
1979 3
1980 5
1981 4
1982 2
1983 2
1984 2
1985 3
1986 3
1987 3
1988 1
1989 2
1990 4
1991 2
1992 3
1993 4
1994 4
1995 5
1996 1
1997 2
1999 2
2000 1
2002 3
2003 1
2004 2
2005 1
2006 4
2007 2
2008 3
2009 1
2010 6
2011 3
2012 4
2013 5
2014 6
2015 10
2016 4
2017 5
2018 6
2019 5
2020 6
2021 7
2022 6
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Editorial Comment.
Robinson LM, Williams TR, Tabakin AL. Robinson LM, et al. Among authors: williams tr. Urol Pract. 2024 Mar;11(2):244-245. doi: 10.1097/UPJ.0000000000000512.01. Epub 2023 Dec 28. Urol Pract. 2024. PMID: 38153024 No abstract available.
The "shaggy esophagus".
Davenport AA, Williams TR, Myers DT. Davenport AA, et al. Among authors: williams tr. Abdom Radiol (NY). 2019 Jan;44(1):385-386. doi: 10.1007/s00261-018-1729-3. Abdom Radiol (NY). 2019. PMID: 30078082 Review. No abstract available.
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Shimura M, Kitano S, Ogata N, Mitamura Y, Oh H, Ochi H, Ohsawa S, Hirakata A; YOSEMITE and RHINE Investigators. Shimura M, et al. Jpn J Ophthalmol. 2023 May;67(3):264-279. doi: 10.1007/s10384-023-00979-8. Epub 2023 Mar 10. Jpn J Ophthalmol. 2023. PMID: 36897413 Free PMC article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
The "Christmas tree" bladder.
Hirshberg BV, Myers DT, Williams TR. Hirshberg BV, et al. Among authors: williams tr. Abdom Radiol (NY). 2018 Dec;43(12):3525-3526. doi: 10.1007/s00261-018-1648-3. Abdom Radiol (NY). 2018. PMID: 29797029 Review. No abstract available.
The "teardrop sign".
Williams PC, Williams TR, Myers DT. Williams PC, et al. Among authors: williams tr. Abdom Radiol (NY). 2019 Feb;44(2):794-795. doi: 10.1007/s00261-018-1738-2. Abdom Radiol (NY). 2019. PMID: 30105401 Review. No abstract available.
The collar button ulcer sign.
Starcevic V, Myers DT, Williams TR. Starcevic V, et al. Among authors: williams tr. Abdom Radiol (NY). 2018 Dec;43(12):3536-3538. doi: 10.1007/s00261-018-1664-3. Abdom Radiol (NY). 2018. PMID: 29948054 Review. No abstract available.
185 results